• About
    • Team
    • Contact
  • Ophthalmics
  • Investors
    • AGM Notices
    • Financials
    • Research & Development
  • News


Genix Pharmaceuticals Corp. Announces AGM Results and Appoints Mahmoud Aziz to the Board and as President

Genix Pharmaceuticals Corporation Provides a Corporate Update To Shareholders

Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange

Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License

Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada

Genix Proposes to Extend Warrants

Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

Genix Announces Auditor Resignation

Genix Announces Change of Auditor

Genix Announces AGM Results

Previous 1 2 3 Next
Suite 300, 1055 West Hastings St, Vancouver, BC, V6E 2E9
604.609.6198
info@genixpharm.com

LINKS

  • Ophthalmics
  • Investors
  • News

OUR COMPANY

  • About
  • Investors
  • Contact
  • Disclaimers
  • Terms of service

OUR NEWSLETTER

Subscribe to the mailing list to receive updates on new arrivals, special offers and other information


© 2022 Created by Genix Pharmaceuticals